These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 9885715)
21. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A; J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703 [TBL] [Abstract][Full Text] [Related]
22. Lymphokines post autologous peripheral blood stem cell transplantation in children. Yaniv I Pediatr Hematol Oncol; 2000; 17(1):9-13. PubMed ID: 10689710 [No Abstract] [Full Text] [Related]
23. [Peripheral blood stem cell transplantation: current status and related issues]. Harada M Rinsho Ketsueki; 2001 Mar; 42(3):145-51. PubMed ID: 11345772 [No Abstract] [Full Text] [Related]
24. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A; Bone Marrow Transplant; 2002 Apr; 29(8):639-46. PubMed ID: 12180107 [TBL] [Abstract][Full Text] [Related]
25. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703 [TBL] [Abstract][Full Text] [Related]
31. Activity survey and historical perspective of autologous stem cell transplantation in Europe. Gratwohl A Semin Hematol; 2007 Oct; 44(4):220-6. PubMed ID: 17961720 [TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
33. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA; Sims-Poston L; Eldridge P; Hale GA Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921 [TBL] [Abstract][Full Text] [Related]
34. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. de Witte T; Brand R; van Biezen A; Delforge M; Biersack H; Or R; Meloni G; Bandini B; Sierra J; Kroger N; Gratwohl A; Niederwieser D; Haematologica; 2006 Jun; 91(6):750-6. PubMed ID: 16769576 [TBL] [Abstract][Full Text] [Related]
35. [Allogeneic hematopoietic stem cell transplantation for solid tumors]. Kanda Y Rinsho Ketsueki; 2004 Mar; 45(3):189-94. PubMed ID: 15103931 [No Abstract] [Full Text] [Related]
36. Autologous stem cell transplantation for pediatric rheumatic diseases. Barron KS; Wallace C; Woolfrey CEA ; Laxer RM; Hirsch R; Horwitz M; Siegel J; Filipovich L; Wulffraat N; Passo M; Rider LG J Rheumatol; 2001 Oct; 28(10):2337-58. PubMed ID: 11669179 [TBL] [Abstract][Full Text] [Related]
37. The clinical and economic rationale for peripheral blood progenitor cell transplantation. Introduction. Yee GC Pharmacotherapy; 1998; 18(1 Pt 2):1S-2S. PubMed ID: 9473172 [No Abstract] [Full Text] [Related]
38. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358 [TBL] [Abstract][Full Text] [Related]
39. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience. Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409 [TBL] [Abstract][Full Text] [Related]
40. Risk assessment in haematopoietic stem cell transplantation: stem cell source. Urbano-Ispizua A Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]